Skip to main content
Sartorius Stedim Biotech S.A. (EPA:DIM)
France flag France · Delayed Price · Currency is EUR
187.15
-4.20 (-2.19%)
Apr 17, 2025, 5:35 PM CET

Sartorius Stedim Biotech Revenue

Sartorius Stedim Biotech had revenue of 744.60M EUR in the quarter ending March 31, 2025, with 11.65% growth. This brings the company's revenue in the last twelve months to 2.86B, up 5.21% year-over-year. In the year 2024, Sartorius Stedim Biotech had annual revenue of 2.78B with 0.16% growth.

Revenue (ttm)
2.86B
Revenue Growth
+5.21%
P/S Ratio
6.37
Revenue / Employee
286.89K
Employees
9,901
Market Cap
18.21B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.78B4.50M0.16%
Dec 31, 20232.78B-717.20M-20.53%
Dec 31, 20223.49B605.70M20.98%
Dec 31, 20212.89B976.92M51.15%
Dec 31, 20201.91B469.51M32.59%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
EssilorLuxottica Société anonyme 26.51B
Sanofi 44.29B
bioMérieux 3.98B
Eurofins Scientific SE 6.95B
Ipsen 3.57B
Virbac 1.40B
emeis Société anonyme 5.43B
Clariane SE 5.28B
Revenue Rankings

Sartorius Stedim Biotech News

More News